Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

ReportBuyer
Posted on: 01 Sep 17
Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 DelveInsight's, Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Sedation.

PR Newswire

LONDON, Aug. 31, 2017

LONDON, Aug. 31, 2017 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5028399/

The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Sedation which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.

Scope
• A review of the marketed products for Sedation including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.
• Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
• API manufacturers for the marketed products with location details
• Emerging Phase III product profiles for Sedation including product description, developmental activities, licensors & collaborators and chemical information

Reasons to Buy
• API intelligence for marketed drugs for the indication and gaining insights of API manufacturers
• Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication
• Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space

Download the full report: https://www.reportbuyer.com/product/5028399/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

View original content:http://www.prnewswire.com/news-releases/sedation---global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2017-300512790.html

SOURCE ReportBuyer

PR Newswire
www.prnewswire.com

Last updated on: 01/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.